1-20 of 47
Shingo Yano
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Short Diagnosis to Treatment Interval Is Associated with Poor Outcomes in Relapse or Refractory Diffuse Large B-Cell Lymphoma

Keita Ishii, Kazuhito Suzuki, Ryoko Fukushima, Tadahiro Gunji, Hiroto Ishii, Masaharu Kawashima, Hideki Uryu, Kurumi Tsukamoto, Kei Hirano, Riku Nagao, Hiroki Yokoyama, Atsushi Katsube, Susumu Tanoue, Yasutaka Mochizuki, Rie Ohba, Daiki Hattori, Mitsuji Katori, Takeshi Saito, Kaichi Nishiwaki, Nobuaki Dobashi, Shingo Yano
Journal: Blood
Blood (2024) 144 (Supplement 1): 3090.
https://doi.org/10.1182/blood-2024-201328
Published: 2024
Journal Articles

Gnri (Geriatric Nutritional Risk Index) in Multiple Myeloma

Kohei Sato, Kazuhito Suzuki, Riku Nagao, Tadahiro Gunji, Masaharu Kawashima, Hideki Uryu, Mamiko Momoki, Hiroto Ishii, Mitsuji Katori, Susumu Tanoue, Atsushi Katsube, Hiroki Yokoyama, Takeshi Saito, Kaichi Nishiwaki, Shingo Yano
Journal: Blood
Blood (2024) 144 (Supplement 1): 1939.
https://doi.org/10.1182/blood-2024-203587
Published: 2024
Journal Articles

Treatment and Outcomes of Stage I-II Pulmonary MALT Lymphoma: A Multi-Institutional Observational Study in Japan

Kazutaka Suzuki, Kana Miyazaki, Naoko Asano, Hiroyuki Takahashi, Nobuhiro Hiramoto, Hiro Tatetsu, Ilseung Choi, Hiroshi Arima, Toshiki Uchida, Dai Maruyama, Takeharu Kato, Junji Hiraga, Nobuhiro Kanemura, Tohru Murayama, Shingo Yano, Shunsuke Ito, Naoki Takahashi, Shinsuke Iida, Tetsu Kobayashi, Motoshi Takao, Isao Tawara, Motoko Yamaguchi
Journal: Blood
Blood (2024) 144 (Supplement 1): 3030.
https://doi.org/10.1182/blood-2024-198992
Published: 2024
Journal Articles

Low Immunoglobulin G and Low Lymphocyte-Monocyte Ratio at the End of Treatment Predict Early Progression in Diffuse Large B-Cell Lymphoma

Hideki Uryu, Masaharu Kawashima, Kazuhito Suzuki, Ryoko Fukushima, Tadahiro Gunji, Hiroto Ishii, Kei Hirano, Riku Nagao, Hiroki Yokoyama, Atsushi Katsube, Susumu Tanoue, Yo Sakayori, Yasutaka Mochizuki, Keita Ishii, Rie Ohba, Kurumi Tsukamoto, Daiki Hattori, Mitsuji Katori, Takeshi Saito, Kaichi Nishiwaki, Nobuaki Dobashi, Shingo Yano
Journal: Blood
Blood (2024) 144 (Supplement 1): 4459.
https://doi.org/10.1182/blood-2024-201850
Published: 2024
Journal Articles

Treatment Outcomes of Adult Patients with B-Cell Acute Lymphoblastic Leukemia Relapsed after Allogeneic Stem Cell Transplant in the Era of Novel Immunochemotherapeutic Agents

Hiroaki Shimizu, Yuho Najima, Shinichi Kako, Takayoshi Tachibana, Akihiko Izumi, Susumu Tanoue, Emiko Sakaida, Takuya Miyazaki, Katsuhiro Shono, Kota Yoshifuji, Shinichiro Machida, Takashi Toya, Noriko Doki, Satoru Takada, Kaoru Hatano, Jun Kato, Satoshi Takahashi, Jun Taguchi, Shingo Yano, Yoshinobu Kanda
Journal: Blood
Blood (2024) 144 (Supplement 1): 3541.
https://doi.org/10.1182/blood-2024-199077
Published: 2024
Journal Articles

The Area Under Tacrolimus Concentrations on Day 14-28 Is the Independent Predictor of the Development of Chronic Gvhd in Patients without Severe Acute Gvhd after Unrelated Allogeneic HSCT

Susumu Tanoue, Hiroki Yokoyama, Hiroto Ishii, Daiki Hattori, Iku Kamitani, Takeshi Saito, Shingo Yano
Journal: Blood
Blood (2023) 142 (Supplement 1): 2191.
https://doi.org/10.1182/blood-2023-180206
Published: 2023
Journal Articles

Geriatric Nutritional Risk Index Is an Important Predictor of Survival in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Iku Kamitani, Hiroki Yokoyama, Hiroto Ishii, Susumu Tanoue, Daiki Hattori, Takeshi Saito, Shingo Yano
Journal: Blood
Blood (2023) 142 (Supplement 1): 4968.
https://doi.org/10.1182/blood-2023-185882
Published: 2023
Journal Articles

A Novel Scoring System Using Geriatric Nutritional Risk Index, C-Reactive Protein, and Disease Status Predicts Survival after Second Allogeneic Stem Cell Transplantation

Yasutaka Sadaga, Yuho Najima, Takayoshi Tachibana, Kaito Harada, Takuya Miyazaki, Takashi Toya, Masatsugu Tanaka, Yukiko Misaki, Hiroki Yokoyama, Shinichiro Fujiwara, Emiko Sakaida, Nobuyuki Aotsuka, Satoshi Takahashi, Akira Yokota, Hiroaki Shimizu, Shinichi Kako, Shingo Yano, Takeshi Kobayashi, Noriko Doki, Yoshinobu Kanda
Journal: Blood
Blood (2023) 142 (Supplement 1): 3606.
https://doi.org/10.1182/blood-2023-174312
Published: 2023
Journal Articles

The Role of High-Dose Regimens Followed By Autologous Stem Cell Transplantation for Salvage Chemotherapy-Sensitive DLBCL Patients

Mamiko Momoki, Atsushi Katsube, Masaharu Kawashima, Kazuhito Suzuki, Ryoko Fukushima, Tadahiro Gunji, Hiroto Ishii, Hideki Uryu, Kaichi Nishiwaki, Shingo Yano
Journal: Blood
Blood (2023) 142 (Supplement 1): 7063.
https://doi.org/10.1182/blood-2023-178631
Published: 2023
Journal Articles

International Collaborative Study to Compare the Prognosis for Acute Leukemia Patients Transplanted with Intensified Myeloablative Regimens

Yasuyuki Arai, Yoshiko Atsuta, Ruta Brazauskas, Naya He, Shahrukh Hashmi, Leslie E. Lehmann, William A. Wood, Jr., Hemalatha G. Rangarajan, Shingo Yano, Shinichi Kako, Masamitsu Yanada, Yukiyasu Ozawa, Noriko Doki, Yoshinobu Kanda, Takahiro Fukuda, Yuta Katayama, Tatsuo Ichinohe, Junji Tanaka, Junya Kanda, Takanori Teshima, Shinichiro Okamoto, Wael Saber
Journal: Blood
Blood (2022) 140 (Supplement 1): 4711–4713.
https://doi.org/10.1182/blood-2022-160305
Published: 2022
Journal Articles

Novel Prediction Models of Nonrelapse Mortality in Patients Specific to Each Reduced-Intensity Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Analysis from the Kanto Study Group for Cell Therapy (KSGCT)

Arata Ishii, Akira Yokota, Emiko Sakaida, Shokichi Tsukamoto, Katsuhiro Shono, Takashi Toya, Yuho Najima, Takeshi Kobayashi, Noriko Doki, Hideki Nakasone, Shinichi Kako, Takayoshi Tachibana, Masatsugu Tanaka, Nobuyuki Aotsuka, Toru Sakura, Shingo Yano, Shin Fujisawa, Yuki Shiko, Yoshihito Ozawa, Chiaki Nakaseko, Yoshinobu Kanda
Journal: Blood
Blood (2022) 140 (Supplement 1): 4709–4710.
https://doi.org/10.1182/blood-2022-168458
Published: 2022
Journal Articles

Allogeneic Stem Cell Transplantation Conditioned with Myeloablative Regimens Containing Total Body Irradiation in Adolescent and Young Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Who Were Treated with Pediatric-Type Chemotherapy

Hiroaki Shimizu, Jun Kato, Shun-ichi Kimura, Takayoshi Tachibana, Kaoru Hatano, Kensuke Usuki, Jun Taguchi, Maki Hagihara, Nobuhiro Tsukada, Kaito Harada, Satoshi Takahashi, Satoru Takada, Emiko Sakaida, Shin Fujisawa, Masahiro Onoda, Nobuyuki Aotsuka, Hiroshi Handa, Yoshihiro Hatta, Reiko Nakaseko, Shingo Yano, Kazuteru Ohashi, Yoshinobu Kanda
Journal: Blood
Blood (2021) 138 (Supplement 1): 2283.
https://doi.org/10.1182/blood-2021-151855
Published: 2021
Journal Articles

Novel Prediction Models of Nonrelapse Mortality in Patients Specific to Each Myeloablative Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Analysis from the Kanto Study Group for Cell Therapy (KSGCT)

Arata Ishii, Akira Yokota, MD PhD, Emiko Sakaida, MDPhD, Shokichi Tsukamoto, MDPhD, Katsuhiro Shono, MD PhD, Takashi Toya, MDPhD, Yuho Najima, MD PhD, Takeshi Kobayashi, MD, Noriko Doki, MD PhD, Hideki Nakasone, MDPhD, Shinichi Kako, MD, Takayoshi Tachibana, MD, Masatsugu Tanaka, MD, Nobuyuki Aotsuka, MD PhD, Toru Sakura, PhD MD, Shingo Yano, MD PhD, Shin Fujisawa, MD, Yuki Shiko, Yohei Kawasaki, Chiaki Nakaseko, MDPhD, Yoshinobu Kanda, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–29.
https://doi.org/10.1182/blood-2020-134539
Published: 2020
Journal Articles

Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Myeloid Leukemia in Japan

Shohei Mizuno, MD PhD, Masamitsu Yanada, Koji Kawamura, Shingo Yano, MD PhD, Masayoshi Masuko, MD, Naoyuki Uchida, MD PhD, Yukiyasu Ozawa, MD PhD, Koji Iwato, Kazuteru Ohashi, MD PhD, Kazuhiro Ikegame, MD PhD, Sung-Won Kim, MD PhD, Masatsugu Tanaka, MD, Tetsuya Eto, MD PhD, Yoshinobu Kanda, MD PhD, Takahiro Fukuda, Yoshiko Atsuta, MD PhD, Akiyoshi Takami, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2045.
https://doi.org/10.1182/blood-2019-122801
Published: 2019
Journal Articles

Tumor-Lysis Syndrome in Relapsed or Refractory Multiple Myeloma Patients Treated with Proteasome Inhibitors

Kazuhito Suzuki, MD, Kaichi Nishiwaki, MD, Tadahiro Gunji, MD, Mitsuji Katori, MD, Rika Hosoba, MD, Kei Hirano, MD, Hidekazu Masuoka, Shingo Yano, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5631.
https://doi.org/10.1182/blood-2018-99-114822
Published: 2018
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia with Pre-Transplant Conditioning Using Fludarabine, Reduced-Dose Cyclophosphamide, and Low-Dose Thymoglobulin:Â Ksgct Prospective Study

Shinichi Kako, MD, Yoshinobu Kanda, MD PhD, Makoto Onizuka, MD PhD, Nobuyuki Aotsuka, Kensuke Usuki, MD PhD, Takayoshi Tachibana, MD, Takeshi Kobayashi, MD, Jun Kato, MD, Shingo Yano, MD PhD, Hiroaki Shimizu, MD PhD, Katsuhiro Shono, Masatsugu Tanaka, MD, Shokichi Tsukamoto, MD, Takehiko Mori, MD PhD, Etsuko Yamazaki, MD PhD, Shinichiro Okamoto, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2101.
https://doi.org/10.1182/blood-2018-99-115105
Published: 2018
Journal Articles

A Phase II Study of THP-COP (pirarubicin, cyclophosphamide, vincristine and prednisolone) in Patients with Newly Diagnosed Advanced Peripheral T-Cell Lymphoma: THP-3 Study of Japan Hematopoietic Malignancy Clinical Study Group (HMCSG)

Michinori Ogura, MD PhD, Ken Ohmachi, MD, Ritsuro Suzuki, MD PhD, Yoshiko Atsuta, MD PhD, Tatsuya Ito, MD, Kazuma Ohyashiki, MD, Shingo Yano, MD PhD, Michihiro Hidaka, MD PhD, Kiyoshi Ando, MD PhD, Noriko Fukuhara, MD PhD, Yoshihisa Morishita, MD PhD, Takayo Suzuki, MD PhD, Kunihiro Tsukasaki, MD PhD, Naoki Kobayashi, MD PhD, Kenji Tsukamoto, MD, Yukiyasu Ozawa, MD PhD, Tomomitsu Hotta, MD PhD, Tomohiro Kinoshita, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2789.
https://doi.org/10.1182/blood.V130.Suppl_1.2789.2789
Published: 2017
Journal Articles

Melphalan Dose in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation with Reduced-Intensity Fludarabine and Melphalan

Kaito Harada, MD, Shinichiro Machida, MD, Masamitsu Yanada, MD PhD, Heiwa Kanamori, MD PhD, Makoto Onizuka, MD PhD, Yukiyasu Ozawa, MD PhD, Hikaru Kobayashi, Masashi Sawa, MD, Junya Kanda, MD, Tatsuo Ichinohe, MD PhD, Yoshiko Atsuta, MD PhD, Shingo Yano, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4585.
https://doi.org/10.1182/blood.V130.Suppl_1.4585.4585
Published: 2017
Journal Articles

Comparison of Reduced-Intensity Conditioning with Fludarabine/Busulfan and Fludarabine/Melphalan in Patients 50 Years or Older

Koji Kawamura, MD, Shinichi Kako, MD, Shuichi Mizuta, MD PhD, Ken Ishiyama, MD PhD, Jun Aoki, MD, Shingo Yano, MD PhD, Takahiro Fukuda, MD, Naoyuki Uchida, MD PhD, Yukiyasu Ozawa, MD PhD, Tetsuya Eto, MD PhD, Koji Iwato, MD, Tatsuo Ichinohe, MD PhD, Yoshiko Atsuta, MD PhD, Yoshinobu Kanda, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3414.
https://doi.org/10.1182/blood.V128.22.3414.3414
Published: 2016
Journal Articles

Clinical Significance of Reactivation of Salivary HHV-6 and HHV-7 in Multiple Myeloma Treated with Novel Agents

Kazuhito Suzuki, MD, Shingo Yano, MD, Nobuyuki Kobayashi, MD PhD, Yoji Ogasawara, MD, Takaki Shimada, MD, Katsuki Sugiyama, MD, Takeshi Saito, MD, Shinobu Takahara, MD, Kazuhiro Kondo, MD PhD, Hiroyuki Yanagisawa, MD PhD, Noriko Usui, MD, Keisuke Aiba, MD
Journal: Blood
Blood (2016) 128 (22): 5633.
https://doi.org/10.1182/blood.V128.22.5633.5633
Published: 2016